Phibro Animal Health (NASDAQ:PAHC) Cut to “Hold” at StockNews.com

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a hold rating in a research report report published on Friday morning.

A number of other analysts also recently weighed in on PAHC. Barclays increased their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $23.64 on Friday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health has a fifty-two week low of $11.98 and a fifty-two week high of $26.55. The stock has a market cap of $957.49 million, a PE ratio of 49.25, a PEG ratio of 0.45 and a beta of 0.52. The firm’s fifty day moving average price is $22.47 and its two-hundred day moving average price is $22.48.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities analysts expect that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.03%. Phibro Animal Health’s payout ratio is currently 100.00%.

Institutional Trading of Phibro Animal Health

A number of large investors have recently bought and sold shares of PAHC. Millennium Management LLC grew its holdings in Phibro Animal Health by 233.0% during the 4th quarter. Millennium Management LLC now owns 207,749 shares of the company’s stock worth $4,363,000 after acquiring an additional 145,359 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in Phibro Animal Health by 56.7% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company’s stock worth $6,325,000 after acquiring an additional 108,918 shares during the period. Hussman Strategic Advisors Inc. acquired a new stake in Phibro Animal Health during the 4th quarter worth about $2,205,000. Nuveen Asset Management LLC grew its holdings in Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after acquiring an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. grew its holdings in Phibro Animal Health by 357.1% during the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock worth $2,730,000 after acquiring an additional 101,560 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.